|

Non Elective Vulnerable Elderly Radiotherapy

RECRUITINGN/ASponsored by Azienda Ospedaliero Universitaria Policlinico Modena
Actively Recruiting
PhaseN/A
SponsorAzienda Ospedaliero Universitaria Policlinico Modena
Started2021-02-20
Est. completion2023-07
Eligibility
Age70 Years+
Healthy vol.Accepted

Summary

To evaluate whether patients defined "non-fit for curative non-surgical radio-chemotherapy" and therefore treated with RT alone addressed only to non-elective sites of disease, could obtain a non-inferior loco-regional control compared to similar historical cohorts.

Eligibility

Age: 70 Years+Healthy volunteers accepted
Inclusion Criteria:

* locally advanced non-metastatic HNSCC patients older than 70 years
* Primary tumor clinically and radiologically detectable and measurable (staging according to ed. TNM VII and also VIII.
* patients defined by the tumor board (ENT, Oncologist, Radiotherapist, Nutritionist) as 1) not eligibles for RTCT / RT-cetuximab treatment 2) not amenable to radical surgery and 3) not candidates for treatments with palliative intent/best supportive care
* Availability of staging with CT/PET for distant metastasis and CT/MRI for primary tumor
* Karnofsky performance status (KPS) ≥60/100
* Oropharynx , Hypopharynx and Larynx, Oral cavity: stage III and IV and Unknown primitive P16-POSITIVE

Exclusion Criteria:

* Age less than 70 years

  * Staging exams done 45 days before the date of the beginning of the treatment
  * Subsites: nasopharynx, salivary glands, paranasal sinuses. Metastatic disease
  * Gross total excision
  * All subsites concerned if N3.
  * Squamous cell neoplasms of the glottic larynx T1-T2 N0.
  * Unknown primary HPV negative or EBV positive.
  * Presence of distant metastases or sub-clavicular lymphadenopathies.
  * Previous surgery on T and/or N except diagnostic tonsillectomy.
  * 3D-conformational radiotherapy technique

Conditions2

CancerSquamous Cell Carcinoma of Head and Neck

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.